Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajime Maeda

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Journal of Diabetes Investigation|May 21, 2014
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patientsAkira Kubota, Hajime Maeda, Akira Kanamori, et al.
BMC Endocrine Disorders|July 4, 2015
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K studyShinichi Umezawa, Akira Kubota, Hajime Maeda, et al.
Journal of Clinical Medicine Research|April 26, 2019
Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K StudyMasahiko Takai, Masashi Ishikawa, Hajime Maeda, et al.
International Journal of Oncology|March 5, 2014
The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancersYusuke Oji, Naoya Tatsumi, Mari Fukuda, et al.
Diabetes Research and Clinical Practice|February 15, 2014
Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K studyMasahiko Takai, Masashi Ishikawa, Hajime Maeda, et al.
Journal of Clinical Medicine Research|July 1, 2015
Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K StudyMasashi Ishikawa, Masahiko Takai, Hajime Maeda, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Journal of Diabetes Investigation|May 21, 2014
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patientsAkira Kubota, Hajime Maeda, Akira Kanamori, et al.
BMC Endocrine Disorders|July 4, 2015
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K studyShinichi Umezawa, Akira Kubota, Hajime Maeda, et al.
Journal of Clinical Medicine Research|April 26, 2019
Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K StudyMasahiko Takai, Masashi Ishikawa, Hajime Maeda, et al.
International Journal of Oncology|March 5, 2014
The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancersYusuke Oji, Naoya Tatsumi, Mari Fukuda, et al.
Diabetes Research and Clinical Practice|February 15, 2014
Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K studyMasahiko Takai, Masashi Ishikawa, Hajime Maeda, et al.
Journal of Clinical Medicine Research|July 1, 2015
Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K StudyMasashi Ishikawa, Masahiko Takai, Hajime Maeda, et al.
Pageof 21